Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Egalet Corp | 29,514 | reported | 03 Jul 2017 | tx 6+100,000−3,224 |
| Avalo Therapeutics, Inc. | 27,934 | reported | 21 May 2026 | tx 14+429,363−151,142 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Avalo Therapeutics, Inc. | 24,300 | 0.00 USD | |
| 06 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 62,500 | 13.43 USD | 10b5-1 |
| 06 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 12,563 | 8.04 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 37,375 | 18.91 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 5,196 | 19.78 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 22,839 | 21.22 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 9,253 | 22.70 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 400 | 23.71 USD | 10b5-1 |
| 06 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 62,500 | 0.00 USD | 10b5-1deriv |
| 06 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 12,563 | 0.00 USD | 10b5-1deriv |
| 26 Feb 2026 | GRANT_AWARD | Avalo Therapeutics, Inc. | 80,000 | 0.00 USD | deriv |
| 10 Dec 2025 | TAX_WITHHOLDING | Avalo Therapeutics, Inc. | 1,016 | 4.10 USD | |
| 28 Jan 2025 | GRANT_AWARD | Avalo Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 24 Jun 2024 | GRANT_AWARD | Avalo Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 03 Jul 2017 | SALE | Egalet Corp | 806 | 2.35 USD | |
| 08 Jun 2017 | GRANT_AWARD | Egalet Corp | 50,000 | 0.00 USD | deriv |
| 03 Apr 2017 | SALE | Egalet Corp | 806 | 5.05 USD | |
| 03 Jan 2017 | SALE | Egalet Corp | 806 | 7.75 USD | |
| 06 Dec 2016 | GRANT_AWARD | Egalet Corp | 50,000 | 0.00 USD | deriv |
| 03 Oct 2016 | SALE | Egalet Corp | 806 | 7.56 USD |